Reovirus-induced apoptosis requires activation of transcription factor NF-κB

Journal of Virology

Volumn 74, Issue 7, 2000, Pages 2981-2989

  Connolly, Jodi L ^a   Rodgers, Steven E ^a   Clarke, Penny ^b   Ballard, Dean W ^a   Kerr, Lawrence D ^a   Tyler, Kenneth L ^b,c   Dermody, Terence S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Neurology ^*  (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REOVIRUS; REPORTER GENE; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; VIRUS EXPRESSION;

EID: 0034099836     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.7.2981-2989.2000     Document Type: Article

References (72)

1. Abbadie, C., N. Kabrun, F. Bouali, B. Vandenbunder, and P. Enrietto. 1993. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75:899-912.
2. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305-1308.
3. Baeuerle, P., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
4. Baeuerle, P., and D. Baltimore. 1989. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 3:1689-1698.
5. Ballard, D. W., E. Bohnlein, J. W. Lowenthal, Y. Wano, B. R. Franza, and W. C. Greene. 1988. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 241:1652-1655.
6. Beg, A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
7. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. J. Baldwin. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB:. a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
8. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
9. Beraud, C., and W. C. Greene. 1996. Interaction of HTLV-1 Tax with human proteasome: implications for NF-kappa B induction. J. Acquired Immunodefic. Syndr. 13(Suppl. 1):S76-S84.
10. Bogyo, M., J. McMaster, M. Gaezynska, D. Tortorella, A. Goldberg, and H. Ploegh. 1997. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HsIV by a new class of inhibitors. Proc. Natl. Acad. Sci. U.S.A. 94:6629-6634.
11. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809-2818.
12. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
13. Bussfeld, D., M. Bacher, A. Mortiz, D. Gemsa, and H. Sprenger. 1997. Expression of transcription factor genes after influenza A virus infection. Immunobiology 198:291-298.
14. Casano, F., A. Rolando, J. Mudgett, and S. Molineaux. 1994. The structure and complete nucleotide sequence of the murine gene encoding interleukin-1 beta converting enzyme (ICE). Genomics 20:474-481.
15. Chakrabarti, A. K., T. Neuberger, T. Russell, N. L. Banik, and G. H. DeVries. 1997. Immunolocalization of cytoplasmic and myelin mCalpain in transfected Schwann cells. II. Effect of withdrawal of growth factors. J. Neurosci. Res. 47:609-616.
16. Chen, B. K., M. B. Feinberg, and D. Baltimore. 1997. The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol. 71:5495-5504.
17. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9:1585-1597.
18. Chene, L., M. T. Nugeyre, F. Barre-Sinoussi, and N. Israel. 1999. High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells. J. Virol. 73:2064-2073.
19. Chesnut, J., A. Baytan, M. Russell, M. Chang, A. Bernard, I. Maxwell, and J. Hoeffler. 1996. Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody. J. Immunol. Methods 193:17-27.
20. Cohen, J. J. 1991. Programmed cell death in the immune system. Adv. Immunol. 50:55-85.
21. DeBiasi, R. L., M. K. T. Squier, B. Pike, M. Wynes, T. S. Dermody, J. J. Cohen, and K. L. Tyler. 1999. Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J. Vi-rol. 73:695-701.
22. DeMartino, G. N., and D. K. Blumenthal. 1982. Identification and partial purification of a factor that stimulates calcium-dependent proteases. Bio-chemistry 21:4297-4303.
23. Duke, R. C., and J. J. Cohen. 1992. Morphological and biochemical assays of apoptosis, p. 17.1-17.16. In J. E. Coligan (ed.), Current Protocols in Immunology, Wiley & Sons, New York, N.Y.
24. Duncan, M. R., S. M. Stanish, and D. C. Cox. 1978. Differential sensitivity of normal and transformed human cells to reovirus infection. J. Virol. 28:444-449.
25. Ernst, H., and A. J. Shatkin. 1985. Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames. Proc. Natl. Acad. Sci. USA 82:48-52.
26. Furlong, D. B., M. L. Nibert, and B. N. Fields. 1988. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 62:246-256.
27. Ghosh, S., A. Gifford, L. Riviere, P. Tempst, G. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019-1029.
28. Greene, W. C., E. Bohnlein, and D. W. Ballard. 1989. HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. Immunol. Today 10:272-278.
29. Grimm, S., M. K. A. Bauer, P. A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134:13-23.
30. Hsu, H., J. Xiong, and D. V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 82:495-504.
31. Jacobs, B. L., and C. E. Samuel. 1985. Biosynthesis of reovirus-specified polypeptides: the reovirus S1 mRNA encodes two primary translation products. Virology 143:63-74.
32. Jung, M., Y. Zhang, S. Lee, and A. Dritschilo. 1995. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκB-α. Science 268: 1619-1621.
33. Leung, K., and G. J. Nabel. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature 333: 776-778.
34. Lin, K. I., S. H. Lee, R. Narayanan, J. Baraban, J. Hardwick, and R. Ratan. 1995. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell Biol. 131:1149-1161.
35. Liu, Z.-G., H. Hsu, D. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
36. Lum, R., S. Kerwar, S. Meyer, M. Nelson, S. Schow, D. Shiffman, M. Wick, and A. Joly. 1998. A new structural class of proteasome inhibitors that prevent NF-kappa B activation. Biochem. Pharmacol. 55:1391-1397.
37. Marianneau, P., A. Cardona, L. Edelman, V. Deubel, and P. Despres. 1997. Dengue virus replication in human hepatoma cells activates NF-κB, which in turn induces apoptotic cell death. J. Virol. 71:3244-3249.
38. May, M. J., and S. Ghosh. 1997. Rel/NF-kappa B and I kappa B proteins: an overview. Semin. Cancer Biol. 8:63-73.
39. Mesnard, J. M., and C. Devaux. 1999. Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein. Virology 257: 277-284.
40. Neuberger, T., A. K. Chakrabarti, T. Russell, G. H. DeVreis, E. L. Hogan, and N. L. Banik. 1997. Immunolocalization of cytoplasmic and myelin mCalpain in transfected Schwann cells. I. Effect of treatment with growth factors. J. Neurosci. Res. 47:521-530.
41. Nibert, M. L., L. A. Schiff, and B. N. Fields. 1996. Reoviruses and their replication, p. 1557-1596. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
42. Oberhaus, S. M., R. L. Smith, G. H. Clayton, T. S. Dermody, and K. L, Tyler. 1997. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J. Virol. 71:2100-2106.
43. O'Brien, V. 1998. Viruses and apoptosis. J. Gen. Virol. 79:1833-1845.
44. Palombella, V., O. Rando, A. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa Bl precursor protein and the activation of NF-kappa B. Cell 78:773-785.
45. Razvi, E. S., and R. M. Welsh. 1995. Apoptosis in viral infections. Adv. Virus Res. 45:1-60.
46. Rodgers, S. E., E. S. Barton, S. M. Oberhaus, B. Pike, C. A. Gibson, K. L. Tyler, and T. S. Dermody. 1997. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J. Virol. 71:2540-2546.
47. Rodgers, S. E., J. L. Connolly, J. D. Chappell, and T. S. Dermody. 1998. Reovirus growth in cell culture does not require the full complement of viral proteins: identification of a σ ls-null mutant. J. Virol. 72:8597-8604.
48. Salamino, F., R. DeTullio, P. Mengotti, P. L. Viotti, E. Melloni, and S. Pontremoli. 1993. Site-directed activation of calpain is promoted by a membrane-associated natural activator protein. Biochem. J. 290:191-197.
49. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
50. Sarkar, G., J. Pelletier, R. Bassel-Duby, A. Jayasuriya, B. N. Fields, and N. Sonenberg. 1985. Identification of a new polypeptide coded by reovirus gene S1. J. Virol. 54:720-725.
51. Scherer, D. C., J. A. Brockman, Z, Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
52. Shen, Y., and T. E. Shenk. 1995. Viruses and apoptosis. Curr. Opin. Genet. Dev. 5:105-111.
53. Shiba, R., H. Ariyoshi, Y. Yano, T. Kawasaki, M. Sakon, J. Kambayashi, and T. Mori. 1992. Purification and characterization of a calpain activator from human platelets. Biochem. Biophys. Res. Commun. 182:461-465.
54. Smith, R. E., H. J. Zweerink, and W. K. Joklik. 1969. Polypeptide components of virions, top components and cores of reovirus type 3. Virology 39:791-810.
55. Sonenshein, G. E. 1997. Rel/NF-κB transcription factors and the control of apoptosis. Semin. Cancer Biol. 8:113-119.
56. Strong, J. E., and P. W. Lee. 1996. The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. J. Virol. 70:612-616.
57. Suzuki, K., T. C. Saido, and S. Hirai. 1992. Modulation of cellular signals by calpain. Ann. N. Y. Acad. Sci. 674:218-227.
58. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567-1574.
59. Taterka, J., M. Sugcliffe, and D. H. Rubin. 1994. Selective reovirus infection of murine hepatocarcinoma cells during cell division. A model of viral liver infection. J. Clin. Investig. 94:353-360.
60. Teodoro, J. G., and P. E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71:1739-1746.
61. Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14:2876-2883.
62. Tyler, K. L., and B. N. Fields. 1996. Reoviruses, p. 1597-1623. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
63. Tyler, K. L., M. K. T. Squier, S. E. Rodgers, B. E. Schneider, S. M. Oberhaus, T. A. Grdina, J. J. Cohen, and T. S. Dermody. 1995. Differences in the capacity of reovirus strains to induce apoptosis are determined by viral attachment protein σ 1. J. Virol. 69:6972-6979.
64. Umansky, V., V. A. Shatrov, V. Lehmann, and V. Schirrmacher. 1996. Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-kappa B. Int. Immunol. 8:491-498.
65. Van Antwerp, D., S. Martin, T. Kafri, D. Green, and I. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
66. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and disassociation. Genes Dev. 9:2723-2735.
67. Virgin, H. W., IV, R. Bassel-Duby, B. N. Fields, and K. L. Tyler. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J. Virol. 62:4594-4604.
68. Virgin, H. W., K. L. Tyler, and T. S. Dermody. 1997. Reovirus, p. 669-699. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, New York, N.Y.
69. Wang, C.-Y., M. Mayo, and A. Baldwin. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784-787.
70. Wu, H., and G. Lozano. 1994. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269:20067-20074.
71. Wyllie, A. H. 1997. Apoptosis: an overview. Br. Med. Bull. 53:451-465.
72. Yoshida, M. 1996. Molecular biology of HTLV-I: recent progress. J. Acquired Immune Defic. Syndr. 13(Suppl. 1):S63-S68.